148 related articles for article (PubMed ID: 15122000)
1. Continuous subcutaneous infusion of opiates at end-of-life.
Anderson SL; Shreve ST
Ann Pharmacother; 2004 Jun; 38(6):1015-23. PubMed ID: 15122000
[TBL] [Abstract][Full Text] [Related]
2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
3. Opioid conversions in acute care.
Patanwala AE; Duby J; Waters D; Erstad BL
Ann Pharmacother; 2007 Feb; 41(2):255-66. PubMed ID: 17299011
[TBL] [Abstract][Full Text] [Related]
4. [Factors that enable the patients to live their life till death at home by controlling cancer-pains with continuous subcutaneous injection of opioids-case reports of 3 patients with a terminal cancer].
Yoshimura M; Takeu R
Gan To Kagaku Ryoho; 2001 Dec; 28 Suppl 1():110-3. PubMed ID: 11787275
[TBL] [Abstract][Full Text] [Related]
5. Intermittent subcutaneous methadone administration in the management of cancer pain.
Centeno C; Vara F
J Pain Palliat Care Pharmacother; 2005; 19(2):7-12. PubMed ID: 16061456
[TBL] [Abstract][Full Text] [Related]
6. [Nociceptive cancer pain in adult patients: statement about guidelines related to the use of antinociceptive medicine].
Binhas M; Krakowski I; Marty J
Ann Fr Anesth Reanim; 2007 Jun; 26(6):502-15. PubMed ID: 17560755
[TBL] [Abstract][Full Text] [Related]
7. Continuous morphine infusions for cancer pain in resource-scarce environments: comparison of the subcutaneous and intravenous routes of administration.
Koshy RC; Kuriakose R; Sebastian P; Koshy C
J Pain Palliat Care Pharmacother; 2005; 19(1):27-33. PubMed ID: 15814512
[TBL] [Abstract][Full Text] [Related]
8. Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis.
Shaladi A; Saltari MR; Piva B; Crestani F; Tartari S; Pinato P; Micheletto G; Dall'Ara R
Clin J Pain; 2007; 23(6):511-7. PubMed ID: 17575491
[TBL] [Abstract][Full Text] [Related]
9. [Parenteral opioids in end-of-life care in cancer patients].
Hattori S; Kimura N; Takatani J; Noguchi T
Gan To Kagaku Ryoho; 2005 Feb; 32(2):161-6. PubMed ID: 15751626
[TBL] [Abstract][Full Text] [Related]
10. Opioid switch in palliative care, opioid choice by clinical need and opioid availability.
Müller-Busch HC; Lindena G; Tietze K; Woskanjan S
Eur J Pain; 2005 Oct; 9(5):571-9. PubMed ID: 16139186
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
[TBL] [Abstract][Full Text] [Related]
12. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis.
O'Connor AB; Zwemer FL; Hays DP; Feng C
Acad Emerg Med; 2009 Jun; 16(6):477-87. PubMed ID: 19426295
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of opioids in the treatment of chronic non-cancer pain.
Trescot AM; Glaser SE; Hansen H; Benyamin R; Patel S; Manchikanti L
Pain Physician; 2008 Mar; 11(2 Suppl):S181-200. PubMed ID: 18443639
[TBL] [Abstract][Full Text] [Related]
14. Overview of oral modified-release opioid products for the management of chronic pain.
Amabile CM; Bowman BJ
Ann Pharmacother; 2006; 40(7-8):1327-35. PubMed ID: 16868222
[TBL] [Abstract][Full Text] [Related]
15. Parenteral morphine prescribing patterns among inpatients with pain from advanced cancer: a prospective survey of intravenous and subcutaneous use.
Walsh D; Perin ML; McIver B
Am J Hosp Palliat Care; 2006; 23(5):353-9. PubMed ID: 17060302
[TBL] [Abstract][Full Text] [Related]
16. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
[TBL] [Abstract][Full Text] [Related]
17. Opioids in pain management of blood-related malignancies.
Niscola P; Scaramucci L; Romani C; Giovannini M; Maurillo L; del Poeta G; Cartoni C; Arcuri E; Amadori S; De Fabritiis P
Ann Hematol; 2006 Aug; 85(8):489-501. PubMed ID: 16572325
[TBL] [Abstract][Full Text] [Related]
18. [Does morphine have a life-shortening effect?].
Baust G
MMW Fortschr Med; 2008 Jan; 149 Suppl 4():144-7. PubMed ID: 18402238
[TBL] [Abstract][Full Text] [Related]
19. Use of opioids in the treatment of severe pain in terminally ill patients--dying should not be painful.
Moynihan TJ
Mayo Clin Proc; 2003 Nov; 78(11):1397-401. PubMed ID: 14601699
[TBL] [Abstract][Full Text] [Related]
20. [Continuous subcutaneous infusion of opioids in cancer patients].
Galamba JM; Olsen AK; Crawford ME; Sjøgren P
Ugeskr Laeger; 1995 Jul; 157(29):4126-30. PubMed ID: 7544511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
